Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Chem Biol Interact ; 399: 111145, 2024 Aug 25.
Article in English | MEDLINE | ID: mdl-39002876

ABSTRACT

Imidacloprid (IMI) is a widely used neonicotinoid insecticide that poses risks for developmental neurotoxicity in mammals. The present study investigated the effects of maternal exposure to IMI on behaviors and adult neurogenesis in the hippocampal dentate gyrus (DG) of rat offspring. Dams were exposed to IMI via diet (83, 250, or 750 ppm in diet) from gestational day 6 until day 21 post-delivery on weaning, and offspring were maintained until adulthood on postnatal day 77. In the neurogenic niche, 750-ppm IMI decreased numbers of late-stage neural progenitor cells (NPCs) and post-mitotic immature granule cells by suppressing NPC proliferation and ERK1/2-FOS-mediated synaptic plasticity of granule cells on weaning. Suppressed reelin signaling might be responsible for the observed reductions of neurogenesis and synaptic plasticity. In adulthood, IMI at ≥ 250 ppm decreased neural stem cells by suppressing their proliferation and increasing apoptosis, and mature granule cells were reduced due to suppressed NPC differentiation. Behavioral tests revealed increased spontaneous activity in adulthood at 750 ppm. IMI decreased hippocampal acetylcholinesterase activity and Chrnb2 transcript levels in the DG on weaning and in adulthood. IMI increased numbers of astrocytes and M1-type microglia in the DG hilus, and upregulated neuroinflammation and oxidative stress-related genes on weaning. In adulthood, IMI increased malondialdehyde level and number of M1-type microglia, and downregulated neuroinflammation and oxidative stress-related genes. These results suggest that IMI persistently affected cholinergic signaling, induced neuroinflammation and oxidative stress during exposure, and increased sensitivity to oxidative stress after exposure in the hippocampus, causing hyperactivity and progressive suppression of neurogenesis in adulthood. The no-observed-adverse-effect level of IMI for offspring behaviors and hippocampal neurogenesis was determined to be 83 ppm (5.5-14.1 mg/kg body weight/day).


Subject(s)
Hippocampus , Maternal Exposure , Neonicotinoids , Neural Stem Cells , Neurogenesis , Nitro Compounds , Prenatal Exposure Delayed Effects , Reelin Protein , Animals , Neurogenesis/drug effects , Pregnancy , Female , Neonicotinoids/toxicity , Rats , Nitro Compounds/toxicity , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/cytology , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Neural Stem Cells/drug effects , Neural Stem Cells/metabolism , Insecticides/toxicity , Male , Cell Proliferation/drug effects , Behavior, Animal/drug effects , Rats, Sprague-Dawley , Oxidative Stress/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL